Shabnoor Iqbal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shabnoor Iqbal has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Farhat Jabeen
Department of Zoology, Government College University Faisalabad, Pakistan Government College University, Faisalabad, Pakistan
6 shared publications- Timothy Omara
Institute of Chemistry of Renewable Resources, Department of Natural Sciences and Sustainable Resources, BOKU University, Tulln, Austria
4 shared publications Ivan Kahwa
Department of Pharmacy, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda
3 shared publications- Ivan Kahwa
Institute for Drug Discovery, Department of Pharmaceutical Biology, Faculty of Medicine, Leipzig University, 04317 Leipzig, Germany
3 shared publications - Muhammad Ajmal Shah
Department of Pharmacy, Hazara University, Mansehra, Pakistan
3 shared publications Azhar Rasul
Department of Zoology, Pakistan Government College University, Government College University Faisalabad, Faisalabad, Pakistan
2 shared publications
Latest Publications
- 23 July 2026
- Published by SAGE Publications in ASSAY and Drug Development Technologies
- Vol. 24 (7) , 560-581
Integrated In Vivo and In Silico Approaches for Targeting JAK2/STAT3/SOCS3: Repurposing Boeravinone B and Resveratrol as Chemopreventive Agents in Colon Cancer
Colon cancer ranks among the most prevalent malignancies worldwide and contributes substantially to cancer-related mortality. This study employed an integrated approach to evaluate the chemopreventive effects of Boeravinone B (BB) and Resveratrol (REV), administered individually and in combination, in the azoxymethane (AOM)-induced rat model of colon cancer, with particular emphasis on cytokine signaling pathways and mitochondrial regulation of apoptosis. The combination of BB (15 mg/kg) and REV (8 mg/kg) exhibited greater efficacy than either treatment alone. These combined treatments (BB + REV) significantly reduced pro-inflammatory cytokines (IL-1β, IL-6, tumor necrosis factor-alpha [TNF-α]), nitro-oxidative stress indicators (NO, iNOS), and histological damage, while promoting mitochondria-mediated apoptosis via modulation of BAX and BCL2. Network analysis revealed that centrality metrics (betweenness, closeness, degree, and stress centrality), identified STAT3, SOCS3, JAK2, BAX, and BCL2 as key hub proteins involved in cytokine signaling and apoptotic pathways. These nodes exhibited the highest centrality values (betweenness: 0.046667 for STAT3/SOCS3/JAK2; degree: 10 for all five proteins), indicating their pivotal roles as therapeutic targets. Molecular docking revealed favorable binding affinities of BB for SOCS3 (−9.0 kcal/mol), BAX (−9.0 kcal/mol), JAK2 (−8.1 kcal/mol), and STAT3 (−7.8 kcal/mol). In comparison, REV exhibited its highest binding affinities for SOCS3 (−7.2 kcal/mol) and BAX (−7.0 kcal/mol). These findings identify SOCS3, BAX, JAK2, and STAT3 as potential molecular targets mediating the combined treatment’s anti-inflammatory and pro-apoptotic effects. This integrated in vivo and in silico study showed that combined BB and REV exerted a stronger chemopreventive effect against AOM-induced colon cancer via complementary mechanisms: restoring mitochondrial adenosine triphosphate synthase (ATPase) activity, suppressing biomarkers of inflammation, nitro-oxidative stress, and apoptosis, with strong binding affinities. These findings support repurposing BB and REV as a multitargeted combination therapy against colon cancer.
- 23 July 2026
- Published by SAGE Publications in ASSAY and Drug Development Technologies
- Vol. 24 (7) , 560-581
Integrated In Vivo and In Silico Approaches for Targeting JAK2/STAT3/SOCS3: Repurposing Boeravinone B and Resveratrol as Chemopreventive Agents in Colon Cancer
Colon cancer ranks among the most prevalent malignancies worldwide and contributes substantially to cancer-related mortality. This study employed an integrated approach to evaluate the chemopreventive effects of Boeravinone B (BB) and Resveratrol (REV), administered individually and in combination, in the azoxymethane (AOM)-induced rat model of colon cancer, with particular emphasis on cytokine signaling pathways and mitochondrial regulation of apoptosis. The combination of BB (15 mg/kg) and REV (8 mg/kg) exhibited greater efficacy than either treatment alone. These combined treatments (BB + REV) significantly reduced pro-inflammatory cytokines (IL-1β, IL-6, tumor necrosis factor-alpha [TNF-α]), nitro-oxidative stress indicators (NO, iNOS), and histological damage, while promoting mitochondria-mediated apoptosis via modulation of BAX and BCL2. Network analysis revealed that centrality metrics (betweenness, closeness, degree, and stress centrality), identified STAT3, SOCS3, JAK2, BAX, and BCL2 as key hub proteins involved in cytokine signaling and apoptotic pathways. These nodes exhibited the highest centrality values (betweenness: 0.046667 for STAT3/SOCS3/JAK2; degree: 10 for all five proteins), indicating their pivotal roles as therapeutic targets. Molecular docking revealed favorable binding affinities of BB for SOCS3 (−9.0 kcal/mol), BAX (−9.0 kcal/mol), JAK2 (−8.1 kcal/mol), and STAT3 (−7.8 kcal/mol). In comparison, REV exhibited its highest binding affinities for SOCS3 (−7.2 kcal/mol) and BAX (−7.0 kcal/mol). These findings identify SOCS3, BAX, JAK2, and STAT3 as potential molecular targets mediating the combined treatment’s anti-inflammatory and pro-apoptotic effects. This integrated in vivo and in silico study showed that combined BB and REV exerted a stronger chemopreventive effect against AOM-induced colon cancer via complementary mechanisms: restoring mitochondrial adenosine triphosphate synthase (ATPase) activity, suppressing biomarkers of inflammation, nitro-oxidative stress, and apoptosis, with strong binding affinities. These findings support repurposing BB and REV as a multitargeted combination therapy against colon cancer.
- Open Access
- 15 September 2025
- Published by IntechOpen
Emerging Therapies Targeting Male Reproductive Aging Processes
Testicular aging represents a complex biological process characterized by progressive structural and functional decline, leading to diminished testosterone production and impaired reproductive capacity. This phenomenon exerts systemic consequences, contributing to sexual dysfunction, metabolic syndrome, osteoporosis, and neurocognitive impairments. Advanced paternal age further compounds reproductive risks, correlating with increased de novo mutations and elevated incidence of genetic disorders in offspring. Current treatments, including testosterone replacement therapy (TRT), improve bone density and metabolic health but do not fully reverse aging effects. Emerging strategies target inflammation and oxidative stress, with COX-2 inhibitors (e.g., NS398) enhancing testosterone synthesis and antioxidants (e.g., vitamins D, C, E, zinc, and selenium) improving sperm quality. Additionally, novel pharmacotherapies for male sexual dysfunction—such as PDE5 inhibitors (sildenafil, vardenafil), Maxi-K channel activators (NS1619), and nitric oxide donors (L-arginine, MED2005)—show potential in improving erectile function and semen parameters. However, responses vary, and dopamine agonists (e.g., cabergoline) are effective only in hyperprolactinemia-related infertility. Combination therapies integrating hormonal and antioxidant treatments may optimize outcomes, but further research is needed to refine dosing, mechanisms, and long-term safety. A personalized, pathophysiology-driven approach is essential for managing age-related testicular dysfunction and preserving male reproductive health.
- 15 September 2025
- Published by IntechOpen
Open AccessEmerging Therapies Targeting Male Reproductive Aging Processes
Testicular aging represents a complex biological process characterized by progressive structural and functional decline, leading to diminished testosterone production and impaired reproductive capacity. This phenomenon exerts systemic consequences, contributing to sexual dysfunction, metabolic syndrome, osteoporosis, and neurocognitive impairments. Advanced paternal age further compounds reproductive risks, correlating with increased de novo mutations and elevated incidence of genetic disorders in offspring. Current treatments, including testosterone replacement therapy (TRT), improve bone density and metabolic health but do not fully reverse aging effects. Emerging strategies target inflammation and oxidative stress, with COX-2 inhibitors (e.g., NS398) enhancing testosterone synthesis and antioxidants (e.g., vitamins D, C, E, zinc, and selenium) improving sperm quality. Additionally, novel pharmacotherapies for male sexual dysfunction—such as PDE5 inhibitors (sildenafil, vardenafil), Maxi-K channel activators (NS1619), and nitric oxide donors (L-arginine, MED2005)—show potential in improving erectile function and semen parameters. However, responses vary, and dopamine agonists (e.g., cabergoline) are effective only in hyperprolactinemia-related infertility. Combination therapies integrating hormonal and antioxidant treatments may optimize outcomes, but further research is needed to refine dosing, mechanisms, and long-term safety. A personalized, pathophysiology-driven approach is essential for managing age-related testicular dysfunction and preserving male reproductive health.
- Open Access
- 16 April 2025
- Published by Springer Nature in Chemistry Africa
- Vol. 8 (7) , 2755-2771
Cannabis sativa L. and Moringa oleifera Lam. Leaf Extracts and Cannabidiol as Multi-Target Inhibitors: Lipoxygenase, Free Radical Scavenging Activity, and in Silico Studies
Effective treatments are needed for inflammatory diseases but conventional medications have side effects. The exploration of natural compounds for therapeutic purposes has gained significant attention in recent years, particularly concerning their potential as multi-target inhibitors in various biological processes and as a safer alternative. Among these compounds, Cannabis sativa L. (C. sativa) and Moringa oleifera Lam. (M. oleifera) have emerged as promising due to their rich phytochemical profiles. The aim of this study was to determine if solvent extracts of C. sativa and M. oleifera and cannabidiol (CBD) alone or in combination had anti-inflammatory and antioxidant properties. This study employed anti-inflammatory (LOX inhibition test) and antioxidant (FRAP and ABTS assay) assays to evaluate the biological potential of two plant species. The primary reason for using combined plant extracts and cannabidiol was to assess their potential synergistic effect, where the combined effect of two or more compounds is greater than the sum of their individual effects owing to interactions among diverse bioactive compounds. Outcomes revealed, the highest total flavonoid content was found in the hexane extracts of C. sativa and M. oleifera (88.68 ± 2.40 µg/mL and 159.91 ± 1.53 µg/mL) while the highest phenolic content was recorded in the propanol extract of C. sativa (57.21 ± 0.79 µg/mL), and methanolic extract of M. oleifera (71.50 ± 1.07 µg/mL) leaves. C. sativa propanol and M. oleifera hexane leaf extracts showed maximum ABTS, Fe³⁺-TPTZ scavenging activity, and 15-lipoxygenase inhibition at 100 µg/mL. The minimum IC50 values were: C. sativa propanol extract (IC50; 457.65 ± 0.33 µg/mL for ABTS: IC50; 69.00 ± 0.35 µg/ mL for Fe³⁺-TPTZ: IC50; 57.95 ± 0.58 µg/mL for 15-LOX initiation), M. oleifera hexane extract (IC50; 340.76 ± 0.23 µg/mL for ABTS: IC50; 22.94 ± 0.61 µg/mL for 15-LOX inhibition). This suggests that the extraction solvent used significantly influenced the bioactive compounds available for antioxidant activity. The combination (1:1) of extracts from C. sativa and M. oleifera or with CBD enhanced the overall Fe3+-TPTZ and ABTS + radical scavenging effect, suggesting potential synergistic effects. The maximum synergistic effect was observed for C. sativa methanol + M. oleifera aqueous extracts (IC50; 291.45 ± 0.33 µg/mL for ABTS) and C. sativa propanol extract + CBD (IC50; 21.65 ± 0.28 µg/mL for Fe³⁺-TPTZ), and C. sativa + M.oleifera aqueous extracts + CBD (IC50; 11.58 ± 0.33 µg/mL). Molecular docking studies revealed that catechin and quercetin exhibited the highest binding interactions with 15-LOX. Experimental results show CBD as a strong inhibitor, but in silico findings suggest a higher affinity for quercetin and catechin due to experimental conditions, metabolism, and concentration. Overall, the study depicted propanol extract of C. sativa and the hexane extract of M. oleifera exerted maximum anti-inflammatory and anti-oxidant effects owing to a considerable amount of phenolic and flavonoid contents. In conclusion, the combination of C. sativa and M. oleifera along with CBD is a suitable option to enhance the efficacy of extracts and might help to overcome multidrug resistance. To validate their use in combination with treating inflammatory diseases, further preclinical trials are required.
- 16 April 2025
- Published by Springer Nature in Chemistry Africa
- Vol. 8 (7) , 2755-2771
Open AccessCannabis sativa L. and Moringa oleifera Lam. Leaf Extracts and Cannabidiol as Multi-Target Inhibitors: Lipoxygenase, Free Radical Scavenging Activity, and in Silico Studies
Effective treatments are needed for inflammatory diseases but conventional medications have side effects. The exploration of natural compounds for therapeutic purposes has gained significant attention in recent years, particularly concerning their potential as multi-target inhibitors in various biological processes and as a safer alternative. Among these compounds, Cannabis sativa L. (C. sativa) and Moringa oleifera Lam. (M. oleifera) have emerged as promising due to their rich phytochemical profiles. The aim of this study was to determine if solvent extracts of C. sativa and M. oleifera and cannabidiol (CBD) alone or in combination had anti-inflammatory and antioxidant properties. This study employed anti-inflammatory (LOX inhibition test) and antioxidant (FRAP and ABTS assay) assays to evaluate the biological potential of two plant species. The primary reason for using combined plant extracts and cannabidiol was to assess their potential synergistic effect, where the combined effect of two or more compounds is greater than the sum of their individual effects owing to interactions among diverse bioactive compounds. Outcomes revealed, the highest total flavonoid content was found in the hexane extracts of C. sativa and M. oleifera (88.68 ± 2.40 µg/mL and 159.91 ± 1.53 µg/mL) while the highest phenolic content was recorded in the propanol extract of C. sativa (57.21 ± 0.79 µg/mL), and methanolic extract of M. oleifera (71.50 ± 1.07 µg/mL) leaves. C. sativa propanol and M. oleifera hexane leaf extracts showed maximum ABTS, Fe³⁺-TPTZ scavenging activity, and 15-lipoxygenase inhibition at 100 µg/mL. The minimum IC50 values were: C. sativa propanol extract (IC50; 457.65 ± 0.33 µg/mL for ABTS: IC50; 69.00 ± 0.35 µg/ mL for Fe³⁺-TPTZ: IC50; 57.95 ± 0.58 µg/mL for 15-LOX initiation), M. oleifera hexane extract (IC50; 340.76 ± 0.23 µg/mL for ABTS: IC50; 22.94 ± 0.61 µg/mL for 15-LOX inhibition). This suggests that the extraction solvent used significantly influenced the bioactive compounds available for antioxidant activity. The combination (1:1) of extracts from C. sativa and M. oleifera or with CBD enhanced the overall Fe3+-TPTZ and ABTS + radical scavenging effect, suggesting potential synergistic effects. The maximum synergistic effect was observed for C. sativa methanol + M. oleifera aqueous extracts (IC50; 291.45 ± 0.33 µg/mL for ABTS) and C. sativa propanol extract + CBD (IC50; 21.65 ± 0.28 µg/mL for Fe³⁺-TPTZ), and C. sativa + M.oleifera aqueous extracts + CBD (IC50; 11.58 ± 0.33 µg/mL). Molecular docking studies revealed that catechin and quercetin exhibited the highest binding interactions with 15-LOX. Experimental results show CBD as a strong inhibitor, but in silico findings suggest a higher affinity for quercetin and catechin due to experimental conditions, metabolism, and concentration. Overall, the study depicted propanol extract of C. sativa and the hexane extract of M. oleifera exerted maximum anti-inflammatory and anti-oxidant effects owing to a considerable amount of phenolic and flavonoid contents. In conclusion, the combination of C. sativa and M. oleifera along with CBD is a suitable option to enhance the efficacy of extracts and might help to overcome multidrug resistance. To validate their use in combination with treating inflammatory diseases, further preclinical trials are required.
- Open Access
- 29 October 2024
- Published by Springer Nature in Advances in Traditional Medicine
- Vol. 25 (2) , 579-595
Protective effects of Sphaeranthus indicus floral extract against BPS-induced testicular damage in rats occurs through downregulation of RIPK1/3-MLK-driven necroptosis and Fas-FasL-mediated apoptosis
Bisphenol S (BPS) is one of the monomers preferred in the manufacturing of polycarbonate plastics. Unfortunately, its estrogenic and genotoxic effects are similar to those of bisphenol A. The protective effects of Sphaeranthus indicus floral extract (SFE) against reprotoxic effects of BPS (50 µg/kg per body weight) in rats exposed to it via drinking water was investigated. Different SFE doses (25, 50, and 100 mg/kg) were administered via oral gavage for 10 weeks. High-performance liquid chromatography (HPLC) results indicated that SFE was rich in polyphenols, with rutin and quercetin being important bioactive molecules modulating BPS-induced necroptosis and apoptosis. Biochemical analyses unveiled that rats administered BPS only exhibited considerable elevation of biomarkers of nitro-oxidative stress, necroptotic (RIPK1/RIPK3 and MLKL), and apoptotic mediators (Fas/FasL and caspase 3/caspase-8). These events caused changes in sperm characteristics (sperm motility, sperm head, and sperm viability), sperm count, and hormonal profile (thyroid stimulating hormone, luteinizing hormone, and follicle-stimulating hormone) of the rats. Histological analysis suggested that there was pronounced sloughing of Sertoli cells, reduced spermatogenic cell density, increased levels of seminiferous tubules, and disorganized morphometric parameters related to seminiferous tubules. The SFE supplementation in rats with BPS-containing water restored nitro-oxidative stress biomarkers, which led to the reduction of necroptosis and apoptosis. Reinstatement of all the biomarkers of oxidative stress, inflammation, necroptosis, and apoptosis after SFE supplementations restored the hormonal profile and normal histoarchitecture of the testes. Virtual screening elucidated that the key regulators of the necroptosis are RIPK3-rutin and RIPK1-quercetin complexes. Further studies are needed to assess its pharmacodynamics, kinetics, and effective concentration for daily use in humans.
- 29 October 2024
- Published by Springer Nature in Advances in Traditional Medicine
- Vol. 25 (2) , 579-595
Open AccessProtective effects of Sphaeranthus indicus floral extract against BPS-induced testicular damage in rats occurs through downregulation of RIPK1/3-MLK-driven necroptosis and Fas-FasL-mediated apoptosis
Bisphenol S (BPS) is one of the monomers preferred in the manufacturing of polycarbonate plastics. Unfortunately, its estrogenic and genotoxic effects are similar to those of bisphenol A. The protective effects of Sphaeranthus indicus floral extract (SFE) against reprotoxic effects of BPS (50 µg/kg per body weight) in rats exposed to it via drinking water was investigated. Different SFE doses (25, 50, and 100 mg/kg) were administered via oral gavage for 10 weeks. High-performance liquid chromatography (HPLC) results indicated that SFE was rich in polyphenols, with rutin and quercetin being important bioactive molecules modulating BPS-induced necroptosis and apoptosis. Biochemical analyses unveiled that rats administered BPS only exhibited considerable elevation of biomarkers of nitro-oxidative stress, necroptotic (RIPK1/RIPK3 and MLKL), and apoptotic mediators (Fas/FasL and caspase 3/caspase-8). These events caused changes in sperm characteristics (sperm motility, sperm head, and sperm viability), sperm count, and hormonal profile (thyroid stimulating hormone, luteinizing hormone, and follicle-stimulating hormone) of the rats. Histological analysis suggested that there was pronounced sloughing of Sertoli cells, reduced spermatogenic cell density, increased levels of seminiferous tubules, and disorganized morphometric parameters related to seminiferous tubules. The SFE supplementation in rats with BPS-containing water restored nitro-oxidative stress biomarkers, which led to the reduction of necroptosis and apoptosis. Reinstatement of all the biomarkers of oxidative stress, inflammation, necroptosis, and apoptosis after SFE supplementations restored the hormonal profile and normal histoarchitecture of the testes. Virtual screening elucidated that the key regulators of the necroptosis are RIPK3-rutin and RIPK1-quercetin complexes. Further studies are needed to assess its pharmacodynamics, kinetics, and effective concentration for daily use in humans.
- Open Access
- 14 August 2024
- Published by Springer Nature in Medicinal Chemistry Research
Anticancer potential of delphinidin and its derivatives: therapeutic and mechanistic insights
Anthocyanins are water-soluble naturally occurring flavonoids present in fruits, flowers, leaves, and roots of fruit plants and vegetables. One of the important anthocyanidin components of red wine and berries is delphinidin (DP). This review provides an update on the potential of DP in cancer therapy, with a further understanding of the mechanisms involved. Delphinidin has been shown to elicit inhibitory effects on catabolizing enzymes of human granulocytes and parasites, TNF-induced COX-2 expression in mouse epidermal cells, and reduce oxidative stress. It also inhibited anchorage-independent growth and caused cell death in breast cancer cell lines. Delphinidin increased Nrf2 expression, increased HO-1 production, and promoted mRNA expression of mitochondrial biogenesis-related factors. Further, DP has anti-proliferative and pro-apoptotic effects in various cancer cell lines such as lung, breast, and ovarian cancer cells. The mTOR-related pathway is the most important signaling pathway in the activation of autophagy, and DP has been shown to exert its cytotoxic effects on cancer cell lines via activating protein kinases. Among DP derivatives, delphinidin-3-O-glucoside has the best anticancer activity because it is easily absorbed. However, the metabolism of DP and its bioavailability in biological systems need to be explored to fully understand its benefits.
- 14 August 2024
- Published by Springer Nature in Medicinal Chemistry Research
Open AccessAnticancer potential of delphinidin and its derivatives: therapeutic and mechanistic insights
Anthocyanins are water-soluble naturally occurring flavonoids present in fruits, flowers, leaves, and roots of fruit plants and vegetables. One of the important anthocyanidin components of red wine and berries is delphinidin (DP). This review provides an update on the potential of DP in cancer therapy, with a further understanding of the mechanisms involved. Delphinidin has been shown to elicit inhibitory effects on catabolizing enzymes of human granulocytes and parasites, TNF-induced COX-2 expression in mouse epidermal cells, and reduce oxidative stress. It also inhibited anchorage-independent growth and caused cell death in breast cancer cell lines. Delphinidin increased Nrf2 expression, increased HO-1 production, and promoted mRNA expression of mitochondrial biogenesis-related factors. Further, DP has anti-proliferative and pro-apoptotic effects in various cancer cell lines such as lung, breast, and ovarian cancer cells. The mTOR-related pathway is the most important signaling pathway in the activation of autophagy, and DP has been shown to exert its cytotoxic effects on cancer cell lines via activating protein kinases. Among DP derivatives, delphinidin-3-O-glucoside has the best anticancer activity because it is easily absorbed. However, the metabolism of DP and its bioavailability in biological systems need to be explored to fully understand its benefits.
- RetractedOpen Access
Gut-Brain Axis: A Cutting-Edge Approach to Target Neurological Disorders and Potential Synbiotic Application
- Open Access
- 6 May 2024
- Published by Springer Nature in In Silico Pharmacology
- Vol. 12 (1) , 1-13
In silico investigation of cannabinoids from Cannabis sativa leaves as a potential anticancer drug to inhibit MAPK-ERK signaling pathway and EMT induction
Genes related to MAPK-ERK signaling pathways, and epithelial-mesenchymal transition induction is evolutionarily conserved and has crucial roles in the regulation of important cellular processes, including cell proliferation. In this study, six cannabinoids from Cannabis sativa were docked with MAPK-ERK signaling pathways to identify their possible binding interactions. The results showed that all the cannabinoids have good binding affinities with the target proteins. The best binding affinities were MEK- tetrahydrocannabinol (– 8.8 kcal/mol) and P13k-cannabinol (– 8.5 kcal/mol). The root mean square deviation was calculated and used two alternative variants (rmsd/ub and rmsd/lb) and the values of rmsd/lb fluctuated 8.6–2.0 Å and for rmsd/ub from 1.0 to 2.0 Å that suggests the cannabinoids and protein complex are accurate and cannot destroy on binding. The study analyzed the pharmacokinetic and drug-likeness properties of six cannabinoids from C. sativa leaves using the SwissADME web tool. Lipinski's rule of five was used to predict drug-likeness and showed that all compounds have not violated it and the total polar surface area of cannabinoids was also according to Lipinski's rule that is benchmarked of anticancer drugs. Cannabinoids are meet the requirements of leadlikeness and synthetic accessibility values showed they can be synthesized. The molecular weight, XLOGP3, solubility (log S), and flexibility (FLEX) are according to the bioavailability radar. The bioavailability score and consensus Log Po/w fall within the acceptable range for the suitable drug. Pharmacokinetics parameters showed that cannabinoids cannot cross the blood–brain barrier, have high GI absorption as well as cannabinoids are substrates of (CYP1A2, CYP2C19, CYP2C9, CYP2D6, and CYP3A4) but no substrate of P-glycoprotein. Based on these findings, the study suggests that cannabinoids are suitable drugs that could be used as effective inhibitors for target proteins involved in cancer pathways. Among the six cannabinoids, cannabinol and tetrahydrocannabinol exerted maximum binding affinities with proteins of MAPK-ERK signaling pathways, and their pharmacokinetics and drug-likeness-related profiles suggest that these cannabinoids could be superlative inhibitors in cancer treatment. Further in vitro, in vivo, and clinical studies are needed to explore their potential in cancer treatment.
- 6 May 2024
- Published by Springer Nature in In Silico Pharmacology
- Vol. 12 (1) , 1-13
Open AccessIn silico investigation of cannabinoids from Cannabis sativa leaves as a potential anticancer drug to inhibit MAPK-ERK signaling pathway and EMT induction
Genes related to MAPK-ERK signaling pathways, and epithelial-mesenchymal transition induction is evolutionarily conserved and has crucial roles in the regulation of important cellular processes, including cell proliferation. In this study, six cannabinoids from Cannabis sativa were docked with MAPK-ERK signaling pathways to identify their possible binding interactions. The results showed that all the cannabinoids have good binding affinities with the target proteins. The best binding affinities were MEK- tetrahydrocannabinol (– 8.8 kcal/mol) and P13k-cannabinol (– 8.5 kcal/mol). The root mean square deviation was calculated and used two alternative variants (rmsd/ub and rmsd/lb) and the values of rmsd/lb fluctuated 8.6–2.0 Å and for rmsd/ub from 1.0 to 2.0 Å that suggests the cannabinoids and protein complex are accurate and cannot destroy on binding. The study analyzed the pharmacokinetic and drug-likeness properties of six cannabinoids from C. sativa leaves using the SwissADME web tool. Lipinski's rule of five was used to predict drug-likeness and showed that all compounds have not violated it and the total polar surface area of cannabinoids was also according to Lipinski's rule that is benchmarked of anticancer drugs. Cannabinoids are meet the requirements of leadlikeness and synthetic accessibility values showed they can be synthesized. The molecular weight, XLOGP3, solubility (log S), and flexibility (FLEX) are according to the bioavailability radar. The bioavailability score and consensus Log Po/w fall within the acceptable range for the suitable drug. Pharmacokinetics parameters showed that cannabinoids cannot cross the blood–brain barrier, have high GI absorption as well as cannabinoids are substrates of (CYP1A2, CYP2C19, CYP2C9, CYP2D6, and CYP3A4) but no substrate of P-glycoprotein. Based on these findings, the study suggests that cannabinoids are suitable drugs that could be used as effective inhibitors for target proteins involved in cancer pathways. Among the six cannabinoids, cannabinol and tetrahydrocannabinol exerted maximum binding affinities with proteins of MAPK-ERK signaling pathways, and their pharmacokinetics and drug-likeness-related profiles suggest that these cannabinoids could be superlative inhibitors in cancer treatment. Further in vitro, in vivo, and clinical studies are needed to explore their potential in cancer treatment.
- Open Access
- 27 March 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (4) , 843-852
Matricin Modulates Carbamazepine-Induced Acute Tubulointerstitial Nephritis in Rat Models of Alzheimer’s Disease via MEK-JAK2-STAT3 Signaling
Carbamazepine is a first-choice anticonvulsant, and its medication is typically well tolerated when compared to lithium and valproic acid. Patients of Alzheimer’s Disease who are administered carbamazepine tend to develop acute tubulointerstitial nephritis. In this study, we established an Alzheimer’s model using scopolamine in Sprague Dawley rats to find out the nephroprotective effect of matricin (a bioactive sesquiterpene isolated from chamomile flowers) against carbamazepine-induced acute tubulointerstitial nephritis and its underlying mechanism of action. Scopolamine (16 mg/kg) was intraperitoneally injected for induction of Alzheimer’s disease on the 28th day whereas carbamazepine (25 mg/kg) was given daily to induce acute tubulointerstitial nephritis. Treatment with matricin inhibited carbamazepine-induced mRNA expressions of RAS-ERK-MEK-JAK2-STAT3, cytokines (IL-1β, TNF-α, and IL-6), and restored the optimal levels of biomarkers of oxidative stress (MDA, SOD and CAT). Further, matricin treatments reinstated biomarkers of kidney function (creatinine, uric acid, and blood urea nitrogen), and refurbished the levels of MDA, SOD, and CAT. Histopathological analyses indicated that there was systemic dilation, tubular necrosis, interstitial edema, and glomerulus nephritis in the medulla region of the kidneys in rats with Alzheimer’s disease that received carbamazepine only. Treatment with matricin reconsolidated histopathology, and only mild glomerulus nephritis were observed in rats with Alzheimer’s disease. These results suggest that matricin could be utilized as a co-supplement with carbamazepine for the treatment of patients with Alzheimer’s disease to minimize the risk of kidney damage.
- 27 March 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (4) , 843-852
Open AccessMatricin Modulates Carbamazepine-Induced Acute Tubulointerstitial Nephritis in Rat Models of Alzheimer’s Disease via MEK-JAK2-STAT3 Signaling
Carbamazepine is a first-choice anticonvulsant, and its medication is typically well tolerated when compared to lithium and valproic acid. Patients of Alzheimer’s Disease who are administered carbamazepine tend to develop acute tubulointerstitial nephritis. In this study, we established an Alzheimer’s model using scopolamine in Sprague Dawley rats to find out the nephroprotective effect of matricin (a bioactive sesquiterpene isolated from chamomile flowers) against carbamazepine-induced acute tubulointerstitial nephritis and its underlying mechanism of action. Scopolamine (16 mg/kg) was intraperitoneally injected for induction of Alzheimer’s disease on the 28th day whereas carbamazepine (25 mg/kg) was given daily to induce acute tubulointerstitial nephritis. Treatment with matricin inhibited carbamazepine-induced mRNA expressions of RAS-ERK-MEK-JAK2-STAT3, cytokines (IL-1β, TNF-α, and IL-6), and restored the optimal levels of biomarkers of oxidative stress (MDA, SOD and CAT). Further, matricin treatments reinstated biomarkers of kidney function (creatinine, uric acid, and blood urea nitrogen), and refurbished the levels of MDA, SOD, and CAT. Histopathological analyses indicated that there was systemic dilation, tubular necrosis, interstitial edema, and glomerulus nephritis in the medulla region of the kidneys in rats with Alzheimer’s disease that received carbamazepine only. Treatment with matricin reconsolidated histopathology, and only mild glomerulus nephritis were observed in rats with Alzheimer’s disease. These results suggest that matricin could be utilized as a co-supplement with carbamazepine for the treatment of patients with Alzheimer’s disease to minimize the risk of kidney damage.
- 7 September 2023
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 23 (9-10) , 295-304
Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways
Thiazolidinediones are useful antidiabetic medications. However, their use is associated with adverse side effects like edema, heart failure and bone fractures. In this study, we investigated the anti-ferroptosis effects of suberosin (SBR; a prenylated coumarin) in diabetic Sprague Dawley rats. Further, we assessed the effects of co-administration of SBR (30 and 90 mg/kg/day) with thiazolidinedione (TZ at 15 mg/kg) to mitigate TZ-induced cardiomyopathy in diabetic rats. Our results showed that cardiac output, stroke volume, left ventricle systolic and diastolic pressures were aggravated in diabetic rats treated with TZ alone after 4 weeks. TZ treatments induced ferroptosis as well as marked histoarchitecture disarrangements in rat cardiomyocytes. The study found that optimizing volume overload alleviated cardiac hypertrophy and mitigated left ventricular dysfunction in diabetic rats co-treated with SBR. SBR co-administration with TZ reduced MDA levels in heart tissue and serum iron concentration (biomarkers of ferroptosis), downregulated mRNA expressions of LOX, ACSL4, LPCAT3, and promoted GPX4 activity as well as upregulated mRNA levels of AKT/PI3K/GSK3β as compared to the group administered with TZ at 15 mg/kg. SBR co-administration also helped to retain the normal histoarchitecture of cardiomyocytes in diabetic rats. Hence, our results suggested that SBR is an effective supplement and could be prescribed to diabetic patients along with TZ but this requires further clinical trials.
- 7 September 2023
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 23 (9-10) , 295-304
Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways
Thiazolidinediones are useful antidiabetic medications. However, their use is associated with adverse side effects like edema, heart failure and bone fractures. In this study, we investigated the anti-ferroptosis effects of suberosin (SBR; a prenylated coumarin) in diabetic Sprague Dawley rats. Further, we assessed the effects of co-administration of SBR (30 and 90 mg/kg/day) with thiazolidinedione (TZ at 15 mg/kg) to mitigate TZ-induced cardiomyopathy in diabetic rats. Our results showed that cardiac output, stroke volume, left ventricle systolic and diastolic pressures were aggravated in diabetic rats treated with TZ alone after 4 weeks. TZ treatments induced ferroptosis as well as marked histoarchitecture disarrangements in rat cardiomyocytes. The study found that optimizing volume overload alleviated cardiac hypertrophy and mitigated left ventricular dysfunction in diabetic rats co-treated with SBR. SBR co-administration with TZ reduced MDA levels in heart tissue and serum iron concentration (biomarkers of ferroptosis), downregulated mRNA expressions of LOX, ACSL4, LPCAT3, and promoted GPX4 activity as well as upregulated mRNA levels of AKT/PI3K/GSK3β as compared to the group administered with TZ at 15 mg/kg. SBR co-administration also helped to retain the normal histoarchitecture of cardiomyocytes in diabetic rats. Hence, our results suggested that SBR is an effective supplement and could be prescribed to diabetic patients along with TZ but this requires further clinical trials.
- Open Access
- 26 June 2023
- Published by Springer Nature in Research Square
Suberosin alleviates thiazolidinedione-induced cardiomyopathy in diabetic rats by inhibiting ferroptosis via modulation of ACSL4-LPCAT3 and PI3K-AKT signaling pathways
Thiazolidinediones are antidiabetic medications that are useful for managing diabetes. However, their use is associated with adverse side effects like edema, heart failure, and bone fractures. In this study, we investigated the anti-ferroptosis effects of suberosin (SBR; a prenylated coumarin) in diabetic Sprague Dawley rats. Further, we assessed the effects of co-administration of SBR (30 and 90 mg/kg/day) with thiazolidinedione TZ (15 mg/kg) to mitigate TZ-induced cardiomyopathy in diabetic rats. Our results showed that cardiac output, stroke volume, left ventricle systolic, and diastolic pressure were aggravated in diabetic rats only treated with TZ after 4 weeks. TZ treatments were induced ferroptosis as well as marked histoarchitecture disarrangements in rat cardiomyocytes. The study was found that optimizing volume overload alleviated cardiac hypertrophy and mitigated left ventricular dysfunction in diabetic rats co-treated with SBR. SBR co-administration with TZ reduced MDA levels in heart tissue and serum iron concentration (biomarkers of ferroptosis) as well as downregulated mRNA expressions of LOX, ACSL4, LPCAT3, and promoted GPX4 activity as well as upregulated mRNA levels of AKT/PI3K/GSK3β in a dose-dependent manner as compared to the group administered with TZ at 15 mg/kg. SBR co-administration was also helped to retain the normal histoarchitecture of cardiomyocytes in diabetic rats. Hence, our results suggested that SBR is an effective supplement and could be prescribed to diabetic patients along with TZ but this will require further clinical trials.
- 26 June 2023
- Published by Springer Nature in Research Square
Open AccessSuberosin alleviates thiazolidinedione-induced cardiomyopathy in diabetic rats by inhibiting ferroptosis via modulation of ACSL4-LPCAT3 and PI3K-AKT signaling pathways
Thiazolidinediones are antidiabetic medications that are useful for managing diabetes. However, their use is associated with adverse side effects like edema, heart failure, and bone fractures. In this study, we investigated the anti-ferroptosis effects of suberosin (SBR; a prenylated coumarin) in diabetic Sprague Dawley rats. Further, we assessed the effects of co-administration of SBR (30 and 90 mg/kg/day) with thiazolidinedione TZ (15 mg/kg) to mitigate TZ-induced cardiomyopathy in diabetic rats. Our results showed that cardiac output, stroke volume, left ventricle systolic, and diastolic pressure were aggravated in diabetic rats only treated with TZ after 4 weeks. TZ treatments were induced ferroptosis as well as marked histoarchitecture disarrangements in rat cardiomyocytes. The study was found that optimizing volume overload alleviated cardiac hypertrophy and mitigated left ventricular dysfunction in diabetic rats co-treated with SBR. SBR co-administration with TZ reduced MDA levels in heart tissue and serum iron concentration (biomarkers of ferroptosis) as well as downregulated mRNA expressions of LOX, ACSL4, LPCAT3, and promoted GPX4 activity as well as upregulated mRNA levels of AKT/PI3K/GSK3β in a dose-dependent manner as compared to the group administered with TZ at 15 mg/kg. SBR co-administration was also helped to retain the normal histoarchitecture of cardiomyocytes in diabetic rats. Hence, our results suggested that SBR is an effective supplement and could be prescribed to diabetic patients along with TZ but this will require further clinical trials.